These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24211813)

  • 1. Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
    Huang H; Wang Y; Jiang C; Lang L; Wang H; Chen Y; Zhao Y; Xu Z
    Pulm Pharmacol Ther; 2014 Jun; 28(1):49-52. PubMed ID: 24211813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Kurahashi H; Yoshioka T; Ariyoshi Y; Kobayashi Y; Araki M; Ishii A; Watanabe M; Uehara S; Watanabe T; Nasu Y
    J Infect Chemother; 2017 Apr; 23(4):214-217. PubMed ID: 28089362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
    Nicolau DP; Sutherland C; Winget D; Baughman RP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):94-8. PubMed ID: 22210007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic system related to pulmonary arterial pressure and lung function of patients with idiopathic pulmonary fibrosis.
    Ban C; Wang T; Zhang S; Xin P; Liang L; Wang C; Dai H
    Clin Respir J; 2017 Sep; 11(5):640-647. PubMed ID: 26425916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
    Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
    Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.
    Meyer A; Buhl R; Magnussen H
    Eur Respir J; 1994 Mar; 7(3):431-6. PubMed ID: 8013597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.
    Capitano B; Mattoes HM; Shore E; O'Brien A; Braman S; Sutherland C; Nicolau DP
    Chest; 2004 Mar; 125(3):965-73. PubMed ID: 15006955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.
    Ronan N; Bennett DM; Khan KA; McCarthy Y; Dahly D; Bourke L; Chelliah A; Cavazza A; O'Regan K; Moloney F; Plant BJ; Henry MT
    Lung; 2018 Oct; 196(5):543-552. PubMed ID: 30066212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.
    Fukihara J; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Furukawa T; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    BMC Pulm Med; 2017 Feb; 17(1):30. PubMed ID: 28166761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.
    Nishikiori H; Chiba H; Ariki S; Kuronuma K; Otsuka M; Shiratori M; Ikeda K; Watanabe A; Kuroki Y; Takahashi H
    BMC Pulm Med; 2014 Dec; 14():196. PubMed ID: 25488319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.